• I-SPY Phase 1

    A Phase Ib clinical trial designed to decrease the amount of time required to collect drug safety data for entry into I-SPY 2.

  • I-SPY 2

    A Phase II neoadjuvant clinical trial designed to decrease the amount of time required to collect drug efficacy data.

  • I-SPY 3

    An international confirmatory Phase III neoadjuvant clinical trial for successful I-SPY 2 agents.

  • I-SPY 2 PATIENT SITE

    Information for interested participants in the I-SPY 2 Clinical Trial.

Long-Term Efficacy Results From The I-SPY2 Trial Indicate Pathological Complete Response (PCR) Is A Powerful Predictor For Breast Cancer Survival


Read More

I-SPY 2 TRIAL predictive biomarker analysis shows promise to improve targeted therapy for high-risk breast cancers 

Read More

Stay in Touch

Subscribe to the I-SPY2 email list and we'll send you occasional updates on trial progress, results and important breast cancer news. Expect about one email a month, and you can unsubscribe at any time.

Subscribe Now